Akèy › Limfom selil mantèl › Kalifòni › Los Angeles
Etid klinik pou Limfom selil mantèl nan Los Angeles, CA
7 etid pou Limfom selil mantèl ap chèche patisipan nan sit nan ak bò kote Los Angeles (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Ap rekriteFaz 3
- Cedars-Sinai Medical Center, Los Angeles
Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Ap rekriteFaz 2
- University of California, Los Angeles, Los Angeles
A Study of ARC-02 in B-cell NHL
Ap rekriteFaz 1
- Start Cala, Los Angeles
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
Ap rekriteFaz 1
- Cedars-Sinai Medical Center, Los Angeles
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Ap rekriteFaz 1/2
- Valkyrie Clinical Trials, Los Angeles
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
Ap rekriteFaz 1
- START Los Angele, Los Angeles
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Ap rekriteFaz 1/2
- Los Angeles Cancer Network, Los Angeles
- UCLA Medical Center of Hematology/Oncology, Los Angeles
Etid Limfom selil mantèl nan lòt vil
- Houston, TX15 etid
- Baldwin Park, CA15 etid
- Durham, NC13 etid
- Seattle, WA12 etid
- New York City, NY12 etid
- Milwaukee, WI12 etid
- Boston, MA11 etid
- Nashville, TN11 etid
- Columbus, OH11 etid
- Chicago, IL10 etid
- Rochester, MN9 etid
- Portland, OR9 etid
Lòt etid nan Los Angeles
- Kansè Poumon ki pa ti selil87 etid
- Kansè (tout kalite)74 etid
- Kansè nan tete73 etid
- Kansè pwostat61 etid
- Kansè kolorektal59 etid
- Kansè Metastatik57 etid
- Kansè ovè50 etid
- Kansè poumon45 etid
- Karsinòm selil skuamèz tèt ak kou42 etid
- Kansè pankreyas35 etid
- Kansè Endomèt34 etid
- Melanom34 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.